Tempus AI
Tempus AI (NASDAQ: TEM) is a precision medicine company that has built one of the world's largest libraries of de-identified clinical and molecular data, paired with an operating system to make that data accessible for diagnostics and research, starting with cancer. Its products span genomic profiling (xT / xR), AI-enabled clinical tools (Hub, One, Next), the Lens real-world data and agentic AI platform for life sciences, cardiology and radiology AI (ECG-AI, Pixel), and a consumer health app (Olivia). Tempus does not currently publish a self-serve, documented public developer API; integrations are delivered through enterprise and EHR channels (HL7 / FHIR, e.g. Epic) under partner agreements.
APIs
Tempus Lens
Lens is Tempus' real-world multimodal data and agentic AI platform for life sciences and oncology drug development, providing exploration of one of the world's largest de-identi...
Tempus One
Tempus One is an AI clinical assistant giving oncology providers voice and text access to patient data, clinical-trial options, and treatment guidelines at the point of care. It...
Tempus Hub
Tempus Hub is the smart physician platform where providers order diagnostic tests, get clinical context on a patient, and receive and review testing results. Access is via the H...
Tempus Next
Tempus Next ingests patient data and applies AI to unstructured elements, evaluating it against care guidelines to identify in near real time patients who have deviated from the...
Tempus EHR Integration
Tempus integrates genomic test ordering and results into clinical workflows using near real-time connections (HL7, FHIR) and batch data exchange, including an integration with E...
Tempus Genomic Profiling (xT / xR)
Tempus xT and xR are DNA and RNA next-generation sequencing assays for oncology. Results are returned through Tempus Hub and EHR integrations rather than a documented public API.